Research Signal – Source date 2022-06-18
A nutritional compound described as acting against cellular senescence could be doing several different things. It might change how a stressed cell responds, reduce the signals a senescent cell releases, or help eliminate the cell itself. Those outcomes carry different biological meanings, even when they appear under the same broad promise of healthier aging.
A narrative review published on June 18, 2022, brings together research on these possibilities across nutrients, plant compounds and probiotics. Its contribution is to explain where nutrition might intersect with senescence. It reports no new intervention trial, and its examples range from cultured cells to animal experiments and observations in people. Reading them together requires keeping track of what each experiment actually changed.
Changing a cell is different from removing it
Senescent cells have entered a state in which they generally stop dividing but remain biologically active. Researchers investigate both the processes that establish this state and the effects these cells have on surrounding tissue. A result described as “anti-senescence” therefore needs a more specific explanation.
Consider genistein, a plant compound discussed in the review. In cultured human umbilical vein endothelial cells—the cells lining those blood vessels—researchers used hydrogen peroxide to induce senescence. Genistein treatment reduced the expression of several associated molecules, including p16 and p21, which help regulate the cell cycle. This is evidence of a change in the cells’ response to the experimental stress. Lower marker expression alone cannot establish whether senescence was prevented, whether an established state was reversed, or whether cells were removed.
Apigenin illustrates another intervention point. In human fibroblast strains, cells that help maintain connective tissue, the review reports that apigenin suppressed the senescence-associated secretory phenotype, or SASP, following stress-induced senescence. SASP refers to the collection of substances senescent cells release, including inflammatory and signaling molecules. These substances can change the behavior of neighboring cells. The reported apigenin result concerned those secretions and their effects on nearby cells; it did not demonstrate selective elimination of the secreting cells.
Selective elimination appears in the review’s discussion of combined dasatinib and quercetin. It describes a mouse experiment involving transplanted senescent cells in which the combination eliminated senescent cells and reduced mortality. Dasatinib is a drug, and this was a combined intervention. The result cannot be assigned to quercetin alone or translated into a claim about eating quercetin-containing foods.
The distinction is practical. A marker measures an aspect of a cell’s state; a secretion measurement describes something the cell sends into its surroundings; selective elimination concerns the cell’s survival. Treating these as interchangeable would turn very different experiments into an apparent body of evidence for a single effect that they did not all test.
Secreted signals also help the body find cells
Senescent-cell secretions are part of an interaction with the immune system. The review describes how some secreted factors attract immune cells to places where senescent cells accumulate. Immune cells, including natural killer cells, can recognize and remove them. Recruitment and clearance help regulate how long senescent cells remain in tissue.
With aging, changes in immune function may weaken that surveillance. The authors discuss evidence that impaired immune-cell killing can allow senescent cells to accumulate alongside chronic inflammation. They also describe mouse findings connecting senescence in blood-forming cells with effects throughout the organism. In this account, senescent-cell accumulation and immune aging can influence one another.
That relationship complicates the idea of simply switching off secretions. Reducing signals that disturb neighboring tissue and reducing signals that recruit clearance mechanisms could have different consequences. Removing a cell also changes the situation differently from leaving it alive with altered secretions. Understanding which signals change, in which tissue and at what stage, matters to interpreting an intervention.
The carbohydrate label hides different biology
The review’s carbohydrate section makes clear why a nutrient category cannot predict a senescence effect. It discusses glucose- and fructose-rich diets that accelerated aging in model organisms, while also describing specific complex carbohydrates investigated for effects that counter aspects of senescence. The authors acknowledge that the relevance of low-carbohydrate diets to aging remains disputed.
One example involves a heteropolysaccharide—a carbohydrate made from different sugar units—derived from the medicinal herb Astragalus membranaceus. In cell and animal experiments, the review reports that it alleviated senescence in liver cells and promoted mitophagy through a pathway involving mTOR. Mitophagy is the removal and recycling of mitochondria, the structures that perform much of a cell’s energy processing.
A separate example concerns Astragalus polysaccharides in rat aortic endothelial cells exposed to glucose. There, researchers reported reduced premature senescence and reduced activation of an inflammatory complex called the inflammasome. The experimental stress, cell type and measured process give that finding its meaning. Calling the intervention a carbohydrate leaves out nearly everything needed to understand why it might behave differently from a sugar-rich model diet.
Gut microbes can change the molecule along the way
A compound’s identity at ingestion is only part of its biological story. The review emphasizes that nutritional molecules interact with gut microbes, which can transform them. The resulting products may have different physiological activity from the compounds originally present in food. Microbial processing can change both the kind and the magnitude of an effect attributed to a dietary ingredient.
This places the gut between food composition and possible effects elsewhere in the body. An experiment exposing cells directly to a parent compound examines one interaction. After ingestion, microbial transformation may change which molecules are available for subsequent absorption and action. The review consequently brings gut microbiota and probiotics into the discussion of senescence, alongside the nutrients themselves.
The authors also describe how microbial communities change with age, diet and disease. That makes the gut an active part of the proposed mechanism, rather than a passive delivery route. Understanding nutritional effects requires following what happens to a molecule as well as identifying what was consumed.
What the human evidence can establish
Vitamin D provides a useful comparison between an experimental intervention and an association in people. The review describes cultured human endothelial cells exposed to doxorubicin, a drug used to induce senescence in that experiment. Vitamin D treatment countered the induced senescence and changed signaling involving IL-10 and FOXO3a. Because researchers applied an intervention under controlled conditions, the experiment addresses how those cells responded to that particular exposure.
The human findings discussed alongside it ask a different question. Several studies associated higher circulating 25-hydroxyvitamin D, a measure of vitamin D status, with longer telomeres. Telomeres are protective structures at chromosome ends, and their shortening is relevant to senescence. But an association between blood vitamin levels and telomere length does not show that supplementation caused the difference. Nor does telomere length by itself measure the burden of senescent cells throughout a person’s tissues.
Connecting these observations to a useful dietary intervention would require evidence across several steps. An ingested compound, or an active product formed from it, would have to reach the relevant tissue at an effective and safe exposure. It would then have to produce the intended cellular change, and that change would have to preserve or improve human function. Neither a cultured-cell response nor a vitamin–telomere association establishes that sequence.
As a narrative synthesis, the review brings together different interventions, stressors and endpoints. Its publication date is not a stated literature-search cutoff. The authors acknowledge limited knowledge of specific nutritional effects and call for further investigation in living organisms. The assembled findings do not establish an effective human dietary or supplement regimen, achievable target-tissue exposures, or long-term benefit from these proposed mechanisms.
What this could change
From the June 2022 perspective, the potential payoff is a way to preserve function as people age. If safe nutritional interventions can produce relevant changes in senescent cells in human tissues—and those changes help tissues keep working—they could eventually help older adults retain function and reduce the burden of age-related disease. That would make the cellular mechanisms useful beyond the laboratory.
Different intervention points could support different approaches, such as limiting the development of senescence or modifying harmful effects of cells already present. The necessary bridge is a demonstrated benefit to people’s functioning and health. Establishing that bridge would turn the biological possibilities assembled here into a practical contribution to healthier aging.
Key Sources
- Primary source: Nutritional components as mitigators of cellular senescence in organismal aging: a comprehensive review.
DOI or Journal Page · Review or Meta-Analysis · 2022-06-18
Keep exploring